Squamous cell carcinoma diagnosed as a suspected neuroendocrine tumor by gallium-68 DOTA-Tyr3-octreotate positron emission tomography scan: A case report

Research output: Contribution to journalArticlepeer-review

Abstract

Gallium-68 DOTA-Tyr3-octreotate positron emission tomography scan is an important radiologic tool for detecting neuroendocrine tumors. It detects neoplasms by capturing the tumor’s increased density of somatostatin receptor expression. However, multiple neoplastic and non-neoplastic entities express somatostatin receptors, which can be misleading for proper diagnosis. Herein, we report a case of squamous cell carcinoma in a 64-year-old male with a medical history of 20-pack-years of smoking in which a neuroendocrine tumor was suspected per positive gallium-68 DOTA-Tyr3-octreotate imaging. He underwent surgical resection and adjuvant radiation with 6-month post-treatment surveillance positron emission tomography/computed tomography imaging pending.

Original languageEnglish (US)
JournalSAGE Open Medical Case Reports
Volume13
DOIs
StatePublished - Jan 1 2025

Keywords

  • Ga-DOTATATE
  • neuroendocrine tumor (NET)
  • PET DOTATATE
  • somatostatin receptor
  • squamous cell carcinoma (SCC)

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Squamous cell carcinoma diagnosed as a suspected neuroendocrine tumor by gallium-68 DOTA-Tyr3-octreotate positron emission tomography scan: A case report'. Together they form a unique fingerprint.

Cite this